Role of traditional healers in the management of severe malaria among children below five years of age: the case of Kilosa and Handeni Districts, Tanzania
2006; 5: 58
Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda
2006; 5: 59
Pitting of malaria parasites and spherocyte formation
2006; 5: 64
Absence of erythrocyte sequestration in a case of babesiosis in a splenectomized human patient
2006; 5: 69
Who sleeps under bednets in Ghana? A doer/non-doer analysis of malaria prevention behaviours
2006; 5: 61
Use of insecticide-treated clothes for personal protection against malaria: a community trial
2006; 5: 63
Estimating the malaria risk of African mosquito movement by air travel
2006; 5: 57
Population dynamics of sporogony for Plasmodium vivax parasites from western Thailand developing within three species of colonized Anopheles mosquitoes
2006; 5: 68
Comparative proteomic analysis of metabolically labelled proteins from Plasmodium falciparum isolates with different adhesion properties
2006; 5: 67
ABO phenotypes and malaria related outcomes in mothers and babies in The Gambia: a role for histo-blood groups in placental malaria?
2006; 5: 72
Genetic diversity of Plasmodium vivax in Kolkata, India
2006; 5: 71
Pattern of cause-specific childhood mortality in a malaria endemic area of Burkina Faso
2006; 5: 47
Psychosis with paranoid delusions after a therapeutic dose of mefloquine: a case report
2006; 5: 74
Treatment-seeking behaviour for malaria in children under five years of age: implication for home management in rural areas with high seasonal transmission in Sudan
2006; 5: 60
A reliable morphological method to assess the age of male Anopheles gambiae
2006; 5: 62
Rethinking the economic costs of malaria at the household level: Evidence from applying a new analytical framework in rural Kenya
2006; 5: 76
Compliance of young children with ITN protection in rural Burkina Faso
2006; 5: 70
Assessment of the therapeutic efficacy of a paediatric formulation of artemether-lumefantrine (Coartesiane®) for the treatment of uncomplicated Plasmodium falciparum in children in Zambia
2006; 5: 75
Safety and efficacy of lumefantrine-artemether (Coartem®) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults
2006; 5: 73
Merozoite surface protein-3α is a reliable marker for population genetic analysis of Plasmodium vivax
2006; 5: 53
Efficacy of bifenthrin-impregnated bednets against Anopheles funestus and pyrethroid-resistant Anopheles gambiae in North Cameroon
2006; 5: 77
Malaria hotspot areas in a highland Kenya site are consistent in epidemic and non-epidemic years and are associated with ecological factors
2006; 5: 78
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
2006; 5: 65
Use of pre-packaged chloroquine for the home management of presumed malaria in Malagasy children
2006; 5: 79
Detection and identification of human Plasmodium species with real-time quantitative nucleic acid sequence-based amplification
2006; 5: 80
Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa
2006; 5: 82
Malaria treatment failures after artemisinin-based therapy in three expatriates: could improved manufacturer information help to decrease the risk of treatment failure ?
2006; 5: 81
Daily temperature profiles in and around Western Kenyan larval habitats of Anopheles gambiae as related to egg mortality
2006; 5: 87
Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine
2006; 5: 84
Laboratory tests of oviposition by the African malaria mosquito, Anopheles gambiae, on dark soil as influenced by presence or absence of vegetation
2006; 5: 88
The impact of endemic and epidemic malaria on the risk of stillbirth in two areas of Tanzania with different malaria transmission patterns
2006; 5: 89
Evaluation of the acquired immune responses to Plasmodium vivax VIR variant antigens in individuals living in malaria-endemic areas of Brazil
2006; 5: 83
Dynamics of immune response and drug resistance in malaria infection
2006; 5: 86
Human malarial disease: a consequence of inflammatory cytokine release
2006; 5: 85
Allelic dimorphism of Plasmodium vivax gam-1 in the Indian subcontinent
2006; 5: 90
Literacy and recent history of diarrhoea are predictive of Plasmodium falciparum parasitaemia in Kenyan adults
2006; 5: 96
Production and validation of durable, high quality standardized malaria microscopy slides for teaching, testing and quality assurance during an era of declining diagnostic proficiency
2006; 5: 92
An in-depth study of patent medicine sellers' perspectives on malaria in a rural Nigerian community
2006; 5: 97
Patterns of malaria-related hospital admissions and mortality among Malawian children: an example of spatial modelling of hospital register data
2006; 5: 93
The 10 kDa domain of human erythrocyte protein 4.1 binds the Plasmodium falciparum EBA-181 protein
2006; 5: 100
Spatial and temporal variation in malaria transmission in a low endemicity area in northern Tanzania
2006; 5: 98
The co-distribution of Plasmodium falciparum and hookworm among African schoolchildren
2006; 5: 99
Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania
2006; 5: 94
Lactate levels in severe malarial anaemia are associated with haemozoin-containing neutrophils and low levels of IL-12
2006; 5: 101
A grid-based infrastructure for ecological forecasting of rice land Anopheles arabiensis aquatic larval habitats
2006; 5: 91
Thick blood film examination for Plasmodium falciparum malaria has reduced sensitivity and underestimates parasite density
2006; 5: 104
Sixth Africa malaria day in 2006: how far have we come after the Abuja Declaration?
2006; 5: 102
Malaria and anaemia among children in two communities of Kumasi, Ghana: a cross-sectional survey
2006; 5: 105
Seroprevalence of malaria in inhabitants of the urban zone of Antananarivo, Madagascar
2006; 5: 106
Decreased availability of antimalarials in the private sector following the policy change from chloroquine to sulphadoxine-pyrimethamine in the Kilombero Valley, Tanzania
2006; 5: 109
Topography and malaria transmission heterogeneity in western Kenya highlands: prospects for focal vector control
2006; 5: 107
PCR detection of Plasmodium falciparum in human urine and saliva samples
2006; 5: 103
An improved and highly sensitive microfluorimetric method for assessing susceptibility of Plasmodium falciparum to antimalarial drugs in vitro
2006; 5: 95
Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia
2006; 5: 108
Integration and mining of malaria molecular, functional and pharmacological data: how far are we from a chemogenomic knowledge space?
2006; 5: 110
Early home-based recognition of anaemia via general danger signs, in young children, in a malaria endemic community in north-east Tanzania
2006; 5: 111
Effective population size of Anopheles funestus chromosomal forms in Burkina Faso
2006; 5: 115
Scanning electron microscopy of the neuropathology of murine cerebral malaria
2006; 5: 116
Molecular surveillance of mutations in the cytochrome b gene of Plasmodium falciparum in Gabon and Ethiopia
2006; 5: 112
Efficacy of three artemisinin combination therapies for the treatmentof uncomplicated Plasmodium falciparum malaria in the Republic of Congo
2006; 5: 113
Survival of immature Anopheles arabiensis (Diptera: Culicidae) in aquatic habitats in Mwea rice irrigation scheme, central Kenya
2006; 5: 114
Consumers stated and revealed preferences for community health workers and other strategies for the provision of timely and appropriate treatment of malaria in southeast Nigeria
2006; 5: 117
Over-diagnosis of malaria is not a lost cause
2006; 5: 120
Reader technique as a source of variability in determining malaria parasite density by microscopy
2006; 5: 118
Detection and clinical manifestation of placental malaria in southern Ghana
2006; 5: 119
Comparison of PCR and microscopy for the detection of asymptomatic malaria in a Plasmodium falciparum/vivax endemic area in Thailand
2006; 5: 121
The use of genotyping in antimalarial clinical trials: a systematic review of published studies from 1995–2005
2006; 5: 122
A community-based health education programme for bio-environmental control of malaria through folk theatre (Kalajatha) in rural India
2006; 5: 123
Caregivers' perceived treatment failure in home-based management of fever among Ugandan children aged less than five years
2006; 5: 124
Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania
2006; 5: 126
IMP PCR primers detect single nucleotide polymorphisms for Anopheles gambiae species identification, Mopti and Savanna rDNA types, and resistance to dieldrin in Anopheles arabiensis
2006; 5: 125
Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria
2006; 5: 127
Total and functional parasite specific IgE responses in Plasmodium falciparum-infected patients exhibiting different clinical status
2007; 6: 1
Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania
2007; 6: 2
Host choice and human blood index of Anopheles pseudopunctipennis in a village of the Andean valleys of Bolivia
2007; 6: 8
Malaria vectors and transmission dynamics in coastal south-western Cameroon
2007; 6: 5
Molecular identification of Palearctic members of Anopheles maculipennis in northern Iran
2007; 6: 6
The impact of a hybrid social marketing intervention on inequities in access, ownership and use of insecticide-treated nets
2007; 6: 13
Overestimating resistance in field testing of malaria parasites: simple methods for estimating high EC50 values using a Bayesian approach
2007; 6: 4
An elaborated feeding cycle model for reductions in vectorial capacity of night-biting mosquitoes by insecticide-treated nets
2007; 6: 10
Post-marketing assessment of content and efficacy of preservatives in artemisinin-derived antimalarial dry suspensions for paediatric use
2007; 6: 12
Modelling the impact of intermittent preventive treatment for malaria on selection pressure for drug resistance
2007; 6: 9
The epidemiology of malaria in adults in a rural area of southern Mozambique
2007; 6: 3
Public-private delivery of insecticide-treated nets: a voucher scheme in Volta Region, Ghana
2007; 6: 14
Treatment of malaria restricted to laboratory-confirmed cases: a prospective cohort study in Ugandan children
2007; 6: 7
Home-based management of fever in rural Uganda: community perceptions and provider opinions
2007; 6: 11
The safety of artemisinins during pregnancy: a pressing question
2007; 6: 15
A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia
2007; 6: 21
Promoter regions of Plasmodium vivax are poorly or not recognized by Plasmodium falciparum
2007; 6: 20
Intermittent preventive treatment for malaria in pregnancy in Africa: What's new, what's needed?
2007; 6: 16
Assembling a global database of malaria parasite prevalence for the Malaria Atlas Project
2007; 6: 17
Prediction of outcome in adults with severe falciparum malaria: a new scoring system
2007; 6: 24
Biology and dynamics of potential malaria vectors in Southern France
2007; 6: 18
Identification of field caught Anopheles gambiae s.s. and Anopheles arabiensis by TaqMan single nucleotide polymorphism genotyping
2007; 6: 23
Medicines informal market in Congo, Burundi and Angola: counterfeit and sub-standard antimalarials
2007; 6: 22
A new ELISA kit which uses a combination of Plasmodium falciparum extract and recombinant Plasmodium vivax antigens as an alternative to IFAT for detection of malaria antibodies
2007; 6: 19
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
2007; 6: 25
Is chloroquine chemoprophylaxis still effective to prevent low birth weight? Results of a study in Benin
2007; 6: 27
Artesunate – amodiaquine combination therapy for falciparum malaria in young Gabonese children
2007; 6: 29
Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka
2007; 6: 28
Bone marrow chimeric mice reveal a dual role for CD36 in Plasmodium berghei ANKA infection
2007; 6: 32
Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
2007; 6: 31
Microsatellite polymorphism within pfcrt provides evidence of continuing evolution of chloroquine-resistant alleles in Papua New Guinea
2007; 6: 34
Indoor collections of the Anopheles funestus group (Diptera: Culicidae) in sprayed houses in northern KwaZulu-Natal, South Africa
2007; 6: 30
The Anopheles dirus complex: spatial distribution and environmental drivers
2007; 6: 26
Epidemiologic aspects of the malaria transmission cycle in an area of very low incidence in Brazil
2007; 6: 33
Large-scale malaria survey in Cambodia: Novel insights on species distribution and risk factors
2007; 6: 37
Synergy between repellents and non-pyrethroid insecticides strongly extends the efficacy of treated nets against Anopheles gambiae
2007; 6: 38
Diagnosis and treatment of malaria in peripheral health facilities in Uganda: findings from an area of low transmission in south-western Uganda
2007; 6: 39
Malaria vaccine efficacy: the difficulty of detecting and diagnosing malaria
2007; 6: 36
Influence of oxygen on asexual blood cycle and susceptibility of Plasmodium falciparum to chloroquine: requirement of a standardized in vitro assay
2007; 6: 44
Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria
2007; 6: 41
Choice of treatment for fever at household level in Malawi: examining spatial patterns
2007; 6: 40
Micro-epidemiology of Plasmodium falciparum malaria: Is there any difference in transmission risk between neighbouring villages?
2007; 6: 46
Amodiaquine failure associated with erythrocytic glutathione in Plasmodium falciparum malaria
2007; 6: 47
Treatment-seeking behaviour for febrile illness in an area of seasonal malaria transmission in rural Ethiopia
2007; 6: 49
Antimalarial drug prescribing practice in private and public health facilities in South-east Nigeria: a descriptive study
2007; 6: 55
Outcome of life-threatening malaria in African children requiring endotracheal intubation
2007; 6: 51
Sub-cellular localization and post-translational modifications of the Plasmodium yoelii enolase suggest moonlighting functions
2007; 6: 45
Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré
2007; 6: 54